These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12492998)

  • 1. Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia.
    Mallari R; Sinclair RD
    Int J Dermatol; 2002 Dec; 41(12):946-7. PubMed ID: 12492998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV; Korchevaia TA; Kravchenko LIa
    Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
    Vexiau P; Chaspoux C; Boudou P; Fiet J; Jouanique C; Hardy N; Reygagne P
    Br J Dermatol; 2002 Jun; 146(6):992-9. PubMed ID: 12072067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
    Brzezińska-Wcisło L
    Wiad Lek; 2003; 56(3-4):202-5. PubMed ID: 12923971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiandrogen treatment of polycystic ovary syndrome.
    Rittmaster RS
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should cyproterone acetate be removed from our prescriptions?].
    Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2019 Dec; 47(12):823-824. PubMed ID: 31634588
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-androgens. Their use in dermatology].
    Montero ED; Arevalo A; Michelotti M
    Med Cutan Ibero Lat Am; 1981; 9(4):275-84. PubMed ID: 6456390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed drug eruption caused by cyproterone acetate.
    Galindo PA; Borja J; Feo F; Gómez E; Chamorro R; Encinas C; García R
    Allergy; 1998 Aug; 53(8):813. PubMed ID: 9722234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new ovulation inhibitor antiandrogen].
    Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
    J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of moderately severe virilism of women with Diane and Androcur 10].
    Döring HF; Ilgner M
    Z Hautkr; 1983 May; 58(10):761-7. PubMed ID: 6224353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate].
    Grund E; Schmidt-Elmendorff H
    Med Welt; 1975 Nov; 26(48):2180-7. PubMed ID: 128684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyproterone acetate in paraphilia.
    Panesar N; Allard B; Pai N; Valachova I
    Aust N Z J Psychiatry; 2011 May; 45(5):428. PubMed ID: 21417675
    [No Abstract]   [Full Text] [Related]  

  • 17. Progestogens with antiandrogenic properties.
    Raudrant D; Rabe T
    Drugs; 2003; 63(5):463-92. PubMed ID: 12600226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
    Marianowski L; Cyganek A; Grzechocińska B
    Wiad Lek; 1994 Oct; 47(19-20):745-6. PubMed ID: 7483620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females.
    Peereboom-Wynia JD; van der Willigen AH; van Joost T; Stolz E
    Acta Derm Venereol; 1989; 69(5):395-8. PubMed ID: 2572103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
    Irani J; Salomon L; Oba R; Bouchard P; Mottet N
    Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.